Depnox SR 150 mg (Tablet (Sustained Release))

Unit Price: ৳ 10.06 (30's pack: ৳ 301.75)

Medicine Details

Title

  • Depnox SR

Categories

  • Anti-depressant medication
  • Smoking cessation aid
  • Pharmacological drugs

Description

  • Selective inhibitor of neuronal re-uptake of catecholamines
  • Minimal effect on re-uptake of serotonin
  • May alter seizure threshold
  • Indicated in the treatment of depression and smoking cessation
  • Usual adult target dose is 300 mg/day
  • Dosage should begin at 150 mg/day and may be increased to 300 mg/day
  • Full antidepressant effect may not be evident until 4 weeks of treatment
  • Recommended lowest dose for maintenance of remission
  • Not recommended for child and adolescent under 18 years of age
  • Should not be given concurrently with or within 14 days of MAOI
  • Interactions with various drugs like alcohol, antimalarials, antipsychotics, etc.
  • Contraindicated in patients with a seizure disorder, bulimia, anorexia nervosa, and allergic response to Bupropion
  • Common side effects include agitation, anxiety, insomnia, dry mouth, headache, nausea, and skin rashes
  • Pregnancy Category C, excretion in human milk, decision on breastfeeding or drug discontinuation should be made
  • Use with extreme caution in patients with history of seizure disorders, severe hepatic cirrhosis, CNS tumor, bipolar depression, psychoses, recent history of myocardial infarction or unstable heart disease, and hepatic or renal impairment
  • Therapeutic class of atypical anti-depressant drugs
  • Storage conditions: Keep below 30°C temperature, away from light & moisture, and out of the reach of children

Indications

  • Depression treatment
  • Smoking cessation

Pharmacology

  • Selective inhibitor of neuronal re-uptake of catecholamines
  • Presumed action mediated by noradrenergic and/or dopaminergic mechanisms

Dosage & Administration

  • Usual adult target dose is 300 mg/day
  • Dosage should begin at 150 mg/day and may be increased to 300 mg/day
  • Full antidepressant effect may not be evident until 4 weeks of treatment
  • Increase in dosage to the maximum of 400 mg/day may be considered for patients with no clinical improvement at 300 mg/day
  • Lowest dose that maintains remission is recommended
  • Acute episodes of depression may require several months or longer of antidepressant drug treatment
  • Not recommended for child and adolescent under 18 years of age

Interaction

  • Should not be given concurrently with or within 14 days of MAOI
  • Use of alcohol should be minimized or avoided completely
  • Interaction with various drugs such as antimalarials, antipsychotics, Quinolones, Tramadol, etc.

Contraindications

  • Contraindicated in patients with a seizure disorder
  • Contraindicated in patients with a current or prior diagnosis of bulimia or anorexia nervosa
  • Concurrent administration with MAO inhibitor is contraindicated
  • Contraindicated in patients who have shown an allergic response to Bupropion or its ingredients

Side Effects

  • Agitation
  • Anxiety
  • Insomnia
  • Dry mouth
  • Headache
  • Nausea
  • Vomiting
  • Skin rashes
  • Hypersensitivity reactions such as pruritus and urticaria
  • Less commonly, angio-oedema, dyspnoea, and anaphylactoid reactions

Pregnancy & Lactation

  • Pregnancy Category C
  • Drug and its metabolites are secreted in human milk

Precautions & Warnings

  • Use with extreme caution in patients with history of seizure disorders
  • Use with caution in patients with bipolar depression or psychoses
  • Use with caution in patients with a recent history of myocardial infarction or unstable heart disease
  • Use with caution in patients with hepatic or renal impairment

Therapeutic Class

  • Atypical anti-depressant drugs

Storage Conditions

  • Keep below 30°C temperature
  • Keep away from light & moisture
  • Keep out of the reach of children

Related Brands